|
1
|
Khrimian L, Obri A, Ramos-Brossier M,
Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T,
Saudou F, et al: Gpr158 mediates osteocalcin's regulation of
cognition. J Exp Med. 214:2859–2873. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Y, Li J, Liao J, Hu Y, Zhang H, Yang
X, Wang Q, Mo Z and Cheng J: Potential protective effect of
osteocalcin in middle-aged men with erectile dysfunction: Evidence
from the FAMHES project. Sci Rep. 8:67212018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang Y, Tan A, Liang D, Yang X, Liao M,
Gao Y, Jiang Y, Yao Z, Lin X, Lu Z, et al: Low osteocalcin level is
a risk factor for impaired glucose metabolism in a Chinese male
population. J Diabetes Investig. 7:522–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin X, Brennan-Speranza TC, Levinger I and
Yeap BB: Undercarboxylated osteocalcin: Experimental and human
evidence for a role in glucose homeostasis and muscle regulation of
insulin sensitivity. Nutrients. 10:8472018. View Article : Google Scholar :
|
|
5
|
Otani T, Matsuda M, Mizokami A, Kitagawa
N, Takeuchi H, Jimi E, Inai T and Hirata M: Osteocalcin triggers
Fas/FasL-mediated necroptosis in adipocytes via activation of p300.
Cell Death Dis. 9:11942018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernandes TAP, Gonçalves LML and Brito
JAA: Relationships between bone turnover and energy metabolism. J
Diabetes Res. 2017:90213142017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zoch ML, Clemens TL and Riddle RC: New
insights into the biology of osteocalcin. Bone. 82:42–49. 2016.
View Article : Google Scholar
|
|
8
|
Edwards BJ: Osteoporosis risk calculators.
J Clin Densitom. 20:379–388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Golob AL and Laya MB: Osteoporosis:
Screening, prevention, and management. Med Clin North Am.
99:587–606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ivanova S, Vasileva L, Ivanova S, Peikova
L and Obreshkova D: Osteoporosis: Therapeutic options. Folia Med
(Plovdiv). 57:181–190. 2015. View Article : Google Scholar
|
|
11
|
Wang C, Meng H, Wang X, Zhao C, Peng J and
Wang Y: Differentiation of bone marrow mesenchymal stem cells in
osteoblasts and adipocytes and its role in treatment of
osteoporosis. Med Sci Monit. 22:226–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Q, Chen Y, Guo L, Jiang T and Lin Z:
miR-23a/b regulates the balance between osteoblast and adipocyte
differentiation in bone marrow mesenchymal stem cells. Bone Res.
4:160222016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma R, Zhu R, Wang L, Guo Y, Liu C, Liu H,
Liu F, Li H, Li Y, Fu M and Zhang D: Diabetic osteoporosis: A
review of its traditional Chinese medicinal use and clinical and
preclinical research. Evid Based Complement Alternat Med.
2016:32183132016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roy B: Biomolecular basis of the role of
diabetes mellitus in osteoporosis and bone fractures. World J
Diabetes. 4:101–113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qi J, Hu KS and Yang HL: Roles of TNF-α,
GSK-3β and RANKL in the occurrence and development of diabetic
osteoporosis. Int J Clin Exp Pathol. 8:11995–12004. 2015.
|
|
16
|
Bahrambeigi S, Yousefi B, Rahimi M and
Shafiei-Irannejad V: Metformin; an old antidiabetic drug with new
potentials in bone disorders. Biomed Pharmacother. 109:1593–1601.
2019. View Article : Google Scholar
|
|
17
|
Takagi S, Miura T, Yamashita T, Ando N,
Nakao H, Ishihara E and Ishida T: Characteristics of diabetic
osteopenia in KK-Ay diabetic mice. Biol Pharm Bull. 35:438–443.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y and Yang JH: Activation of the
PI3K/Akt pathway by oxidative stress mediates high glucose-induced
increase of adipogenic differentiation in primary rat osteoblasts.
J Cell Biochem. 114:2595–2602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Zhang X, Zheng J and Yang J: High
glucose stimulates adipogenic and inhibits osteogenic
differentiation in MG-63 cells through cAMP/protein kinase
A/extracellular signal-regulated kinase pathway. Mol Cell Biochem.
338:115–122. 2010. View Article : Google Scholar
|
|
20
|
Liu J and Yang J: Uncarboxylated
osteocalcin inhibits high glucose-induced ROS production and
stimulates osteoblastic differentiation by preventing the
activation of PI3K/Akt in MC3T3-E1 cells. Int J Mol Med.
37:173–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clemmensen C, Smajilovic S, Wellendorph P
and Brauner-Osborne H: The GPCR, class C, group 6, subtype A
(GPRC6A) receptor: From cloning to physiological function. Br J
Pharmacol. 171:1129–1141. 2014. View Article : Google Scholar :
|
|
22
|
Pi M, Xu F, Ye R, Nishimoto SK, Kesterson
RA, Williams RW, Lu L and Quarles LD: Humanized GPRC6A(KGKY) is a
gain-of-function polymorphism in mice. Sci Rep. 10:111432020.
View Article : Google Scholar
|
|
23
|
Pi M, Nishimoto SK and Quarles LD: GPRC6A:
Jack of all metabolism (or master of none). Mol Metab. 6:185–193.
2016. View Article : Google Scholar
|
|
24
|
Pi M, Wu Y and Quarles LD: GPRC6A mediates
responses to osteocalcin in beta-cells in vitro and pancreas in
vivo. J Bone Miner Res. 26:1680–1683. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Otani T, Mizokami A, Hayashi Y, Gao J,
Mori Y, Nakamura S, Takeuchi H and Hirata M: Signaling pathway for
adiponectin expression in adipocytes by osteocalcin. Cell Signal.
27:532–544. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karsenty G and Oury F: Regulation of male
fertility by the bone-derived hormone osteocalcin. Mol Cell
Endocrinol. 382:521–526. 2014. View Article : Google Scholar
|
|
27
|
Smajilovic S, Clemmensen C, Johansen LD,
Wellendorph P, Holst JJ, Thams PG, Ogo E and Bräuner-Osborne H: The
L-α-amino acid receptor GPRC6A is expressed in the islets of
Langerhans but is not involved in L-arginine-induced insulin
release. Amino Acids. 44:383–390. 2013. View Article : Google Scholar
|
|
28
|
Chen JH, Lin X, Bu C and Zhang X: Role of
advanced glycation end products in mobility and considerations in
possible dietary and nutritional intervention strategies. Nutr
Metab (Lond). 15:722018. View Article : Google Scholar
|
|
29
|
Deng A, Zhang H, Hu M, Liu S, Gao Q, Wang
Y and Guo C: Knockdown of Indian hedgehog protein induces an
inhibition of cell growth and differentiation in osteoblast
MC3T3-E1 cells. Mol Med Rep. 16:7987–7992. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smilic TN, Novakovic TR,
Markovic-Jovanovic SR, Smilic LLJ, Mitic JS and Radunovic ML: The
relevance of osteoclastic and osteoblastic activity markers
follow-up in patients on antiresorptive osteoporosis treatment. J
Clin Densitom. 21:322–328. 2018. View Article : Google Scholar
|
|
31
|
Khosla S and Hofbauer LC: Osteoporosis
treatment: Recent developments and ongoing challenges. Lancet
Diabetes Endocrinol. 5:898–907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu C, Zhang X, Ye F and Yang J: High
insulin levels in KK-Ay diabetic mice cause increased cortical bone
mass and impaired trabecular micro-structure. Int J Mol Sci.
16:8213–8226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verma H and Garg R: Comment on 'bone
regulates glucose metabolism as an endocrine organ through
osteocalcin'. Int J Endocrinol. 2016:97249292016. View Article : Google Scholar
|
|
34
|
Wang J, Yan DD, Hou XH, Bao YQ, Hu C,
Zhang ZL and Jia WP: Association of bone turnover markers with
glucose metabolism in Chinese population. Acta Pharmacol Sin.
38:1611–1617. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu JM, Rosen CJ, Ducy P, Kousteni S and
Karsenty G: Regulation of glucose handling by the skeleton:
Insights from mouse and human studies. Diabetes. 65:3225–3232.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mizokami A, Kawakubo-Yasukochi T and
Hirata M: Osteocalcin and its endocrine functions. Biochem
Pharmacol. 132:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tao SC and Guo SC: Extracellular vesicles
in bone: 'Dogrobbers' in the 'eternal battle field'. Cell Commun
Signal. 17:62019. View Article : Google Scholar
|
|
38
|
Pi M, Kapoor K, Ye R, Nishimoto SK, Smith
JC, Baudry J and Quarles LD: Evidence for osteocalcin binding and
activation of GPRC6A in β-cells. Endocrinology. 157:1866–1880.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dumitru N, Carsote M, Cocolos A, Petrova
E, Olaru M, Dumitrache C and Ghemigian A: The link between bone
osteocalcin and energy metabolism in a group of postmenopausal
women. Curr Health Sci J. 45:47–51. 2019.PubMed/NCBI
|
|
40
|
Ye R, Pi M, Cox JV, Nishimoto SK and
Quarles LD: CRISPR/Cas9 targeting of GPRC6A suppresses prostate
cancer tumorigenesis in a human xenograft model. J Exp Clin Cancer
Res. 36:902017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
De Toni L, De Filippis V, Tescari S,
Ferigo M, Ferlin A, Scattolini V, Avogaro A, Vettor R and Foresta
C: Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D
production in Leydig cell line through a GPRC6a-dependent pathway.
Endocrinology. 155:4266–4274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang XL, Wang YN, Ma LY, Liu ZS, Ye F and
Yang JH: Uncarboxylated osteocalcin ameliorates hepatic glucose and
lipid metabolism in KKAy mice via activating insulin signaling
pathway. Acta Pharmacol Sin. 41:383–393. 2020. View Article : Google Scholar :
|
|
43
|
Liu Z and Yang J: Uncarboxylated
osteocalcin promotes osteogenic differentiation of mouse bone
marrow-derived mesenchymal stem cells by activating the
Erk-Smad/β-catenin signalling pathways. Cell Biochem Funct.
38:87–96. 2020. View Article : Google Scholar
|
|
44
|
Camerino C, Conte E, Cannone M, Caloiero
R, Fonzino A and Tricarico D: Nerve growth factor, brain-derived
neurotrophic factor and osteocalcin gene relationship in energy
regulation, bone homeostasis and reproductive organs analyzed by
mRNA quantitative evaluation and linear correlation analysis. Front
Physiol. 7:4562016. View Article : Google Scholar : PubMed/NCBI
|
